SCHEMBL6563676

SCHEMBL6563676

CC(C)(C)OC(=O)NC(=N)c1ccc(NCC#Cc2ccc(C(=O)c3cccnc3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 3/20 0.42
PTPN11 Q06124 1/20 0.41
PPARG P37231 3/20 0.36
PPARA Q07869 3/20 0.36
PPARD Q03181 2/20 0.36
RAB9A P51151 3/20 0.36
GALR3 O60755 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
BCL2 P10415 1/20 0.35
CYP17A1 P05093 1/20 0.34
GBA1 P04062 1/20 0.34
ALDH1A1 P00352 2/20 0.34
KMT2A Q03164 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6563070 0.90 PTPN11 (0.44) NAMPTPTPN11PPARGPPARAPPARD
SCHEMBL6563729 0.83 PPARG (0.41) PTPN11PPARGPPARAPPARD
SCHEMBL7676492 0.81 CCNA2 (0.41) NAMPTRAB9AGALR3TDP1ALDH1A1
SCHEMBL6565434 0.81 PTPN11 (0.41) PTPN11PPARGPPARAPPARDKMT2A
SCHEMBL6563355 0.80 PTPN11 (0.47) PTPN11PPARGPPARAPPARDCYP17A1
SCHEMBL6563589 0.80 GALR3 (0.50) NAMPTRAB9AGALR3TDP1ALDH1A1
SCHEMBL6563283 0.80 PTPN11 (0.46) PTPN11CYP17A1ALDH1A1
SCHEMBL7686729 0.77 PTPN11 (0.43) NAMPTPTPN11ALDH1A1KMT2A
SCHEMBL7674981 0.77 ABL1 (0.43) NAMPTPTPN11RAB9AALDH1A1KMT2A
SCHEMBL6563536 0.76 PPARG (0.39) PTPN11PPARGPPARAPPARDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140802-B1 SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINES BOEHRINGER INGELHEIM PHARMA (DE) 2004-03-17 EP disclosed
US-6479524-B1 TO PROLONG THE THROMBIN TIME BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-11-12 US disclosed